Opioid 411 in 2022 2-Hour

Live Interactive 2-Hour Webinar November 17 | Anytime On-Demand 2-Hour Course available after December 17 | Medical and Non-Medical RACE-approved CE

About This Course

Early-Bird 10% discount: Enroll before October 28 and use coupon code OPIOID22EARLY at checkout

After you enroll, you will be registered for the Live Interactive Opioid 411 in 2022 2-Hour webinar on November 17, 2022 (5 p.m. Pacific, 7 p.m. Central, 8 p.m. Eastern).

This course fulfills mandates in states that require 1 or 2 hours of opioid CE. (Click here to check your state requirements).

After attending the webinar, you will receive a certificate for 2 RACE-approved hours.

Whether you attend the webinar or not, you also will be enrolled in the Anytime On-Demand version of Opioid 411 in 2022 2-Hour, to be published by December 17, 2022. When you complete the On-Demand version, you will receive a separate certificate for 2 RACE-approved hours in addition to the hours you might have earned in the webinar.

You will receive email notifications with your webinar link, and an email notification when you are enrolled in the On-Demand version of the course.

Presenters, Agenda, Learning Objectives

Lance M. Roasa, DVM, JD
Introduce the topic, review statistics & discuss federal controlled substance laws
Review best practices for prescribing controlled substances, including benzodiazepine & opioid medications
Discuss dispensing of controlled substances
Review use of state electronic PDMP systems

Bree Montana, DVM, CCFP
Review how to recognize substance abuse
Discuss the signs of opioid abuse & addiction
Review opioid use & dependency in office staff, clients & co-workers

Philip J. Seibert, Jr., CVT
Review the management of controlled substances, including benzodiazepine & opioid medications
Discuss the signs of opioid diversion Review the use, misuse, documentation & safeguarding of controlled substances
Discuss monitoring controlled substances
Review controlled substance diversion inventory & security

Rachael E. Carpenter, DVM
Review the treatment of chronic pain
Discuss alternatives to controlled substance prescribing for chronic pain management